Page last updated: 2024-11-06

8-hydroxyloxapine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

8-hydroxyloxapine is a hydroxylated derivative of the antipsychotic drug Loxapine. It is a potent dopamine D2 receptor antagonist, and has been investigated for its potential therapeutic effects in various neurological and psychiatric disorders, including schizophrenia, depression, and anxiety. The compound exhibits a wide range of pharmacological properties, including antipsychotic, anxiolytic, and antidepressant effects. Research has focused on exploring its mechanism of action, its potential therapeutic applications, and its safety profile. 8-hydroxyloxapine is a promising candidate for drug development, particularly for the treatment of psychiatric disorders.'

8-hydroxyloxapine: active metabolite of loxapine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID43655
MeSH IDM0108101

Synonyms (16)

Synonym
8-hydroxyloxapine
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepin-3-ol
2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepin-8-ol
FT-0669711
unii-0q6hmm3xrc
dibenz(b,f)(1,4)oxazepin-8-ol, 2-chloro-11-(4-methyl-1-piperazinyl)-
0q6hmm3xrc ,
61443-77-4
8-hydroxy loxapine
2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepin-8-ol #
VNJRIWXLPIYFGI-UHFFFAOYSA-N
DTXSID80210387
AKOS028114539
dibenz[b,f][1,4]oxazepin-8-ol, 2-chloro-11-(4-methyl-1-piperazinyl)-
Q27237099
PD060513

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Estimates of average bioavailability (AUC- infinity, AUC0t and Cmax) were obtained by the difference of the least squares means of log test and log reference."( The role of metabolites in a bioequivalence study 1: loxapine, 7-hydroxyloxapine and 8-hydroxyloxapine.
Hawes, EM; Hsia, D; Hubbard, JW; McKay, G; Midha, KK, 1993
)
0.51

Dosage Studied

ExcerptRelevanceReference
" In the present randomized crossover study to evaluate the bioequivalence of two dosage forms containing loxapine, the parent drug and its 7-hydroxy and 8-hydroxy metabolites were monitored for up to 96 hours after the administration of the test or reference formulations."( The role of metabolites in a bioequivalence study 1: loxapine, 7-hydroxyloxapine and 8-hydroxyloxapine.
Hawes, EM; Hsia, D; Hubbard, JW; McKay, G; Midha, KK, 1993
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]